EuroFlow™ Screening Tubes For efficient, optimized and reproducible screening of hematological malignancies

EuroFlow™ Screening Tubes Standardizing Analysis In response to the clear need for a more efficient and standardized approach to classifying hematological malignancies, the EuroFlow™ Consortium spent several years validating multicolor antibody combinations, resulting in the EuroFlow™ product line of preselected and lyophilized antibody panels.1 The EuroFlow™ panels offer a comprehensive method for the proficient screening of suspected leukemia, myeloma and lymphoma samples. A cytometrist also has access to online SOPs for guidance on instrument set up, calibration, compensation, sample preparation...

Acute Leukemia Screening Tube (ALOT) • Pre-mixed, lyophilized combination of 8 antibodies • Optimized for recognition of BCP-ALL, T-ALL, AML and acute leukemias of ambiguous lineage The ALOT kit contains a combination of 8 antibodies designed for the initial assessment of the nature of immature populations of hemaotpoietic cells in acute leukemia samples to allow appropriate orientation towards a full BCP-ALL, T-ALL and/or AML/MDS characterization panel. Technicians can compensate using the reagents provided with the ALOT screening kit. There is no need to cocktail antibodies or validate fluorochrome...

LST/SST Follow Up NK-CLPD Pacific Blue™ Pacific Orange™ Pacific Pacific Blue™ Orange™ PCST Follow Up • B-CLPD panel LFor Research Use Only Version 25APR14 Works Cited 1. Van Dongen JJM, et al. Leukemia. 2012; 26: 1908-197 3. ARUP Consult, Topics. 2006. Accessed 10NOV13. <http://www.arupconsult.com/Topics/PlasmaCellDyscrasias.htm 4. ARUP Consult, Alogorithms. 2006. Accessed 10NOV13. <http://www.arupconsult.com/Algorithms/PlasmaCellDyscrasias.pd 5. Kyle RA, et al. Leukemia. 2009; 23(1): 3-9 Additional References Additional publications related to EuroFlow™ Consortium and EuroFlow™ product line...